Articles

Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion

Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo;Department of Hematology/Oncology, Tokyo Metropolitan Children’s Medical Center, Fuchu-shi
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo;Department of Pediatrics, St. Luke’s International Hospital, Chuo-ku, Tokyo
Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo
Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Chuo-ku, Tokyo
Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama-shi, Kanagawa
Department of Systems BioMedicine, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo;Division of Pediatric Hematology and Oncology, Ibaraki Children’s Hospital, Mito-shi
Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo
Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Chuo-ku, Tokyo
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo
Department of Pediatrics, Dokkyo Medical University, Tochigi
Department of Pediatrics, St. Luke’s International Hospital, Chuo-ku, Tokyo
Department of Pediatrics, University of Tsukuba Hospital, Ibaraki
Department of Pediatrics, Japanese Red Cross Musashino Hospital, Tokyo
Department of Pediatrics, Yokohama City University Hospital, Kanagawa
Department of Pediatrics, Tokai University School of Medicine, Kanagawa
Department of Pediatrics, Matsudo City Hospital, Chiba
Department of Pediatrics, Japanese Red Cross Maebashi Hospital, Gunma
Department of Hematology/Oncology, Saitama Children’s Medical Center
Department of Pediatrics, Saitama Medical Center, Saitama Medical University
Department of Pediatrics, Japanese Red Cross Narita Hospital, Chiba
Department of Hematology/Oncology, Gunma Children’s Medical Center, Shibukawa-shi
Department of Pediatrics, Nippon Medical School, Bunkyo-ku, Tokyo
Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama-shi, Kanagawa
Laboratory of Clinical Genome Sequencing Department of Computational Biology and Medical Sciences Graduate School of Frontier Sciences, The University of Tokyo, Minato-ku
Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Chuo-ku, Tokyo
Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo
Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo
Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama-shi, Kanagawa
Director, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo
Department of Pediatrics, Toho University Omori Medical Center, Tokyo
Department of Child Health, Faculty of Medicine, University of Tsukuba, Ibaraki
Institute of Physiology and Medicine, Jobu University, Takasaki-shi, Gunma, Japan
Department of Hematology/Oncology, Saitama Children’s Medical Center
Department of Pediatrics, St. Luke’s International Hospital, Chuo-ku, Tokyo
Department of Pediatrics, Toho University Omori Medical Center, Tokyo
Vol. 104 No. 1 (2019): January, 2019 https://doi.org/10.3324/haematol.2017.186320